3 completed, 1 active not recruiting, 1 terminated, 1 withdrawn. 6 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 6 | Completed 3, Active not recruiting 1, Terminated 1, Withdrawn 1 |
Follow Myeloma: new trials by email Literature Review of Myeloma trials Research Report on Myeloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma DKK1 - Monoclonal Gammopathy, Smoldering Myeloma | Early Phase 1 | Withdrawn | Case Comprehensive Cancer Center | 2023-12-01 | 2023-08-18 | |
| Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT Hyperbaric oxygen - Myeloma | Early Phase 1 | Completed | University of Rochester | 29 | 2022-04-22 | 2025-09-10 |
| PET Imaging of Subjects Using 124I-PU-AD PU-AD, PET Scan, Blood Draws - Lymphoma, Solid Malignancy | Early Phase 1 | Terminated | Samus Therapeutics, Inc. | 5 | 2016-04-01 | 2023-04-18 |
| Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma Lenalidomide, Dexamethasone, and MEDI-551 - Myeloma | Early Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 20 | 2014-05-01 | 2018-09-10 |
| Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine Hydroxychloroquine, Rapamycin - Myeloma | Early Phase 1 | Completed | Abramson Cancer Center at Penn Medicine | 6 | 2011-06-01 | 2013-02-26 |
| PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study PET Imaging using 124 IPUH71 - Non-Hodgkin's Lymphoma, Myeloma | Early Phase 1 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 63 | 2010-12-01 | 2026-01-15 |
Neoplasms, Plasma Cell (6) · Alzheimer Disease (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Paraproteinemias (1) · Smoldering Multiple Myeloma (1)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Blood Protein Disorders (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Dementia (1) · Hematologic Diseases (1) · Hypergammaglobulinemia (1) · Lymphoma (1) · Mental Disorders (1)
Blood Specimen Collection (1) · Dexamethasone (1) · Hydroxychloroquine (1) · Hyperbaric Oxygenation (1) · Lenalidomide (1) · Positron-Emission Tomography (1) · Sirolimus (1) · inebilizumab (1)
Abramson Cancer Center at Penn Medicine (1) · Case Comprehensive Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · Samus Therapeutics, Inc. (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · University of Rochester (1)
United States (6)
Carol Ann Huff, MD (1) · Dan Vogl, MD (1) · Ehsan Malek, MD (1) · Mark Dunphy, DO (1) · Omar Aljitawi, MMBS (1) · Robert Morgan, MS, JD (1)
R37CA225791 (1)